Canaccord Genuity Starts Harpoon Therapeutics (HARP) at Buy
Tweet
Share
E-mailGet Alerts HARP Hot Sheet
Price: $23.01 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 58
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 6 | New: 58
Join SI Premium – FREE
Canaccord Genuity analyst Arlinda Lee initiates coverage on Harpoon Therapeutics (NASDAQ: HARP) with a Buy rating and a price target of $24.00.
For an analyst ratings summary and ratings history on Harpoon Therapeutics click here. For more ratings news on Harpoon Therapeutics click here.
Shares of Harpoon Therapeutics closed at $17.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
- JPMorgan Starts Anker Innovations Technology (668:HK) at Overweight
- Piper Sandler Assumes Veeva Systems (VEEV) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
